Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of enzyme inhibitors and receptor antagonists. Its structure supports the construction of bioactive molecules with improved metabolic stability and binding affinity. Commonly employed in medicinal chemistry for optimizing lead compounds in drug discovery programs, especially in treatments targeting central nervous system disorders and inflammatory diseases. The Boc-protected azetidine scaffold allows for selective functionalization, making it valuable in creating diverse compound libraries for biological screening.